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Introduction: Crocus sativus L. (saffron) has many biological effects such as antioxidant property. The
present study investigated the immunomodulatory effects of the aqueous saffron extract on
streptozotocin (STZ)-induced diabetic rats.
Materials and methods: In this study, the rats were divided into the following groups of 9 animals each:
control, untreated diabetic, three saffron extract-treated diabetic groups. Diabetes was induced by STZ in
rats. Saffron was administered 3 days after STZ administration; these injections were continued to the
end of the study (4 weeks). At the end of the 4-week period, blood was drawn for biochemical assays and
the abdominal aorta was removed for detecting the inﬂammatory cytokines expression.
Results: We showed that the saffron decreased blood glucose, malondialdehyde, nitric oxide, total lipids,
triglycerides, cholesterol levels signiﬁcantly (p < 0.01) and increased glutathione level, catalase,
and superoxide dismutase activities in the saffron-treated diabetic groups compared with the untreated
groups, in a dose dependent manner (p < 0.05, p < 0.01, p < 0.001). On the other hand, saffron-treated
diabetic rats inhibited the expression of inﬂammatory cytokines in the abdominal aorta versus the
untreated diabetic rats.
Conclusion: Our results validate the use of saffron as a treatment against diabetes mellitus and its
vascular complications.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Diabetes mellitus (DM) is a chronic disease that occurs when
the pancreases do not produce enough insulin or alternatively,
when the body cannot effectively use the insulin it produces, and
its incidence is considered to be high (4–5%) all over the world.1
DM is the principal factor responsible for renal failure, blindness
and non-traumatic amputations; the connection between diabetes
with poor metabolic control and the high prevalence of mortality
due to coronary heart disease, retinopathy, nephropathies and
neuropathies has been well established.2–4 Furthermore, diabetes
mellitus in turn leads to hyperlipidemia to cardiovascular
morbidity and mortality. Nevertheless, control of plasma glucose
and lipid concentrations inhibit micro-vascular complications.5
Hyperglycemia, the hallmark of diabetes, is believed to generate* Corresponding author.
E-mail address: samarghandians@mums.ac.ir (S. Samarghandian).
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0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).reactive oxygen species (ROS) that eventually lead to oxidative
stress and microvascular complications in several organs. Vascular
complications are the major cause of morbidity and mortality in
patients with DM, which include macrovascular and microvascular
disorders.6 Macrovascular injury includes coronary artery disease,
atherosclerosis, and peripheral vascular disease.2 The cardinal
pathological mechanism of macrovascular disease is the process of
atherosclerosis, resulting in narrowed arteries throughout the
body.7 Accumulating evidence suggests that inﬂammation plays a
central role in the pathophysiology of diabetes-accelerated
atherosclerosis, starting from initiation through progression and,
ultimately, the thrombotic complications of atherosclerosis, and
thus can be used to predict future cardiovascular risk by
monitoring inﬂammatory biomarkers and to serve as a therapeutic
target for atherosclerotic diseases.8 Supra physiological levels of
glucose are notorious to provoke these changes in the vascular
causing diabetic vasculopathy.9 Besides, growing evidence suggest
that elevation in circulating lipids may also contribute to vascular
disease progression.10 There is overwhelming evidence thatulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
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accelerated atherosclerosis and endothelial dysfunction in DM.11
Activation of proinﬂammation genes thought to induce the
transcription of a large range of genes implicated in vascular
inﬂammation, including cytokines [e.g. tumor necrosis factor-
alpha (TNF-a), interleukin-6 (IL-6), and interleukin-1beta (IL-1b)],
adhesion molecules [e.g. inter cellular adhesion molecule-1 (ICAM-
1)], chemokines, and other growth factors,12 which suggest that
some of these genes are a key regulator in the initiation and
development of vascular inﬂammation. Emerging evidence now
indicates that DM is an inﬂammatory disease and that certain
inﬂammatory markers seem to play major roles in the pathophys-
iology of diabetic vascular complications.13 The mechanisms
responsible are suggested to be hyperglycemia-induced ROS
generation of AGEs, activation of proinﬂammatory cascades and
stimulation of glomerular mesangial cells to produce extracellular
matrix proteins.14
Among the cytokines, TNF-a can promote local ROS generation
resulting in alterations in glomerular permeability leading to
albuminuria.15 There is enough evidence that serum and urinary
TNF-a levels are signiﬁcantly upregulated in various complication
of DM including diabetes nephropathy (DN).16 More recent studies
in diabetic patients demonstrate signiﬁcant association between
DN and IL-6, another proinﬂammatory cytokine. IL-6 mediates
glomerular basement membrane thickening, a crucial lesion of DN,
and is a strong predictor of progression of diabetes complica-
tions.17–19
Moreover, implication of oxidative stress in the pathogenesis of
diabetes is suggested, not only by oxygen free radical generation,
but also due to nonenzymatic protein glycosylation, auto-
oxidation of glucose, impaired glutathione metabolism, alteration
in antioxidant enzymes and lipid peroxides formation.20 Cellular
defense against free radical injury is provided by enzymatic
(catalase (CAT), superoxide dismutases (SOD), and glutathione
peroxidase) and nonenzymatic (gluthatione (GSH), a-tocopherol,
vitamin C, and urate) free radical scavenging systems, present in
the cell.21 Although, there is treatment available for diabetes, the
drugs used are associated with undesirable side effects and high
cost for patients, which in recent years have led to intense research
in alternative therapies such as medicinal plants that provide an
effective, reliable and cheap treatment option. Recent overwhelm-
ing attention to plant products and alternative medicine has
encouraged plant chemists, pharmacologists, biochemists, and
molecular biologists to combine their efforts in a search for natural
agents that can limit free radical mediated injuries during and
following diabetes mellitus, for better therapeutic management of
diabetes.
Crocus sativus L. (saffron) is a perennial stem less herb which
belongs to the Iridaceae family. It is widely cultivated in Iran and
other countries.22 In traditional medicine, as well as in modern
pharmacology, saffron has been used in the treatment of numerous
diseases. It was reported that saffron and its constituents have
antitumor,23 anti-inﬂammatory, antinociceptive,24 antioxidant,25
antidepressant,26 hypolipidemic,27 and could improve memory as
well learning abilities in rats.28,29 Evidence showed that saffron and
its constituents reduced lipid peroxidation in various tissues25,30,31
following oxidative damages in rats. Furthermore radical scaveng-
ing effect of saffron extract and its bioactive constituents, safranal
and crocin have been shown previously using DPPH (1,1-diphenyl-
2-picryl-hydrazyl) radical scavenging test.32
Thus, the present study was designed to evaluate the effects of
saffron on the plasma levels of glucose, lipids, oxidant antioxidant
balance and also, we shall investigate the changes of proinﬂam-
matory genes (TNF-a and IL-6) expression in the abdominal aorta
to verify the protective effects of saffron on vascular complication
of DM in rats.Please cite this article in press as: Samarghandian S, et al. Immunomod
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2.1. Chemicals
All puriﬁed enzymes, coenzymes, substrates, standards, buffers,
kits and other chemicals were purchased from Sigma Chemicals
Corporation, MO, USA.
2.2. Animals
Adult male Wistar rats (weight 250–300 g) were provided by
the university experimental animal care center. Rats were kept in
their own cages at constant room temperature (21  2 8C) under a
normal 12-h light/dark cycle with free access to food and water. These
conditions were maintained constant throughout the experiments.
The animals were housed according to regulations for the Welfare of
experimented animals. The study was conducted in Mashhad Medical
University Experimental Animal Research Laboratory. Protocols were
approved by the Ethical Committee (The Ethical Research Committee
of Mashhad University of Medical Sciences).
2.3. Plant
The saffron used in this study was collected from a private
garden and identiﬁed by botanists in the herbarium of Ferdowsi
University of Mashhad (specimen number 293-0303-1).
2.4. Preparation of aqueous saffron extract
Aqueous extract of saffron was prepared by maceration
method. Brieﬂy, 8 g of stigma powder was macerated in 300 ml
distilled water for 72 h with continuous shaking in the refrigerator.
Supernatant was separated by centrifuging and transferred to a
freeze drier (FD-5003-BT, DENA, Iran). After 24 h, lyophilized
powder of extract was available. The aqueous extract was
dissolved in saline (0.9% NaCl). Saline (0.9% NaCl) was used as
negative control. The extract yield was 54% (w/w).
2.5. Streptozotocin-induced diabetic rats
On the ﬁrst day of the study, the diabetic groups were given
streptozotocin (STZ) (dissolved in freshly prepared 0.01 M citrate
buffer, pH 4.5) in a single intraperitoneal (i.p.) injection at a dose of
60 mg/kg for induction of diabetes. Blood was extracted from the
tail vein for measuring the fasting glucose concentration 72 h after
streptozotocin injection. Rats with blood glucose levels higher than
250 mg/dl were accepted as being diabetic.
2.6. Experimental design
45 male Wistar albino rats were randomly allotted to ﬁve
experimental groups (n = 9 per group) as follows: group 1, control
(C); group 2, diabetic (D); group 3, diabetic and saffron extract-
treated (10 mg/kg/day) (D + Saf1); group 4, diabetic and saffron
extract-treated (20 mg/kg/day) (D + Saf2); group 5, diabetic and
saffron extract-treated (40 mg/kg/day) (D + Saf3). In the control
groups (C), physiological saline (i.p.) was injected as vehicle.
Saffron extract (i.p. injection) was administered to the treatment
groups from 3 days after STZ administration; these injections were
continued to the end of the study (for 4 weeks). Blood glucose level
and body weights were recorded at weekly intervals. At the end of
the 4-week period, animals were killed by Pentobarbital overdose
(150 mg/kg, i.p.), and blood was subsequently collected from the
retro orbital sinus and the abdominal aorta was removed, cleaned,
dried and homogenized in 0.1 M Tris–HCl buffer, pH 7.4. Blood,
plasma, and aorta homogenate were used for the followingulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
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3000 rpm for 10 min for glucose, lipid proﬁle, malondialdehyde
(MDA), GSH, CAT, SOD and nitric oxide (NO) assays.
2.7. Measurement of blood glucose
Glucose concentrations were measured with the Ames One
Touch glucometer (One-Touch Basic; Lifescan, Johnson and
Johnson, New Brunswick, NJ) in rat tail vein blood. Blood glucose
was estimated using the diagnostic kits (Pars Azmoon kit, IRI) on an
automatic analyzer (Abbott, model Alcyon 300, USA).
2.8. Measurement of serum lipid proﬁle
The concentrations of glucose, total lipids, triglycerides, total
cholesterol, low-density lipoprotein (LDL) cholesterol and high-
density lipoprotein (HDL) cholesterol in serum were estimated by
using diagnostic kits (Pars Azmoon kit, IRI) on an automatic
analyzer (Abbott, model Alcyon 300, USA).
2.9. Measurement of serum reduced glutathione (GSH)
GSH was determined by the method of Ellman.33 To the
homogenate was added 10% of trichloracetic acid (TCA) and
centrifuged. 1.0 ml of supernatant was treated with 0.5 ml of
Ellman’s reagent (19.8 mg of 5,50-dithiobisnitro benzoic acid
(DTNB) in 100 ml of 0.1% sodium nitrate) and 3.0 ml of phosphate
buffer (0.2 M, pH 8.0). The absorbance was read at 412 nm.33
2.10. Measurement of serum thiobarbituric acid reactive substance
(TBARS)
The formation of lipid peroxides was measured in the serum.
The formation of MDA, an end product of fatty acid peroxidation
was measured spectrophotometrically at 532 nm by using a
thiobarbituric acid reactive substance (TBARS), essentially by the
method of Genet et al.34 Results are expressed as nmole of MDA
formed/mg protein.34
2.11. Measurement of serum superoxide dismutase (SOD) activity
The activity of SOD was determined by a method using
inhibition of pyrogallol autoxidation at pH 8.35 The speciﬁc activity
of SOD is expressed as units per mg protein per minute.
2.12. Measurement of serum catalase (CAT) activity
Catalase activity was assayed by H2O2 consumption, following
Aebi’s36 method and modiﬁed by Pieper et al.37 Brieﬂy, ethanol was
added (1:100, v/v) to the supernatants and incubated for 30 min in
an ice bath. 1% Triton X-100 (1:10, v/v) (Sigma Chemicals
Corporation, MO, USA) was then added to the homogenates. This
solution was placed in an ice bath for an additional 15 min. 500 ml
of this solution was placed into a glass cuvette and 250 ml of 30 mM
H2O2 (Sigma Chemicals Corporation, MO, USA) in phosphate buffer
(50 mM, pH 7.0) was then added to start the reaction. After 15 s the
absorbance at 240 nm was read every 15 s for 45 s. Catalase activity
was expressed as mmol H2O2/min/mg protein. An enzyme unit was
deﬁned as the amount of enzyme that catalyzes the release of one
mmol of H2O2 per min. Speciﬁc activity was calculated in terms of
units per mg of protein. The assay was performed at 25 8C.36,37
2.13. Measurement of serum nitric oxide (NO)
NO levels are determined spectrophotometrically by measuring
the accumulation of its stable degradation products, nitrite andPlease cite this article in press as: Samarghandian S, et al. Immunomod
sativus L.) on streptozotocin-induced diabetes in rats, Indian Heart Jnitrate. The serum nitrite level was determined by the Griess
reagent according to Hortelano et al.38 The Griess reagent, a
mixture (1:1) of 1% sulfanilamide in 5% phosphoric acid and 0.1% 1-
naphthyl ethylenediamine gives a red violent diazo color in the
presence of nitrite. The color intensity was measured at 540 nm.
Results were expressed as mol/l using a NaNO2 calibration graph.
38
2.14. Measurement of serum protein content
Protein content was determined by the method of Lowry et al.
(1951), using bovine serum albumin (BSA) as a standard.39
2.15. RNA extraction and RT-PCR analysis
Expression of proinﬂammatory genes (TNF-a and IL-6) were
examined using reverse transcriptase-PCR (RT-PCR). Samples of
0.5–1 cm obtained from the abdominal aorta of rats of the
experimental groups were deposited in RNAlaterTM solution
(Sigma Chemicals Corporation, MO, USA). Then it was stored at
70 8C for further processing. The samples were processed by the
TRizol LS ReagentTM (Sigma Chemicals Corporation, MO, USA)
technique. The assay was performed according to the protocol
provided by the manufacturer. Brieﬂy, 250 ml of TRIzol LS Reagent
was added for each 50 mg of tissue and they were homogenized.
RNA was extracted from each homogenate by adding 50 ml
chloroform per 250 ml of the TRIzol LS Reagent used. Shake tubes
vigorously by vortexing (15 s) and incubate them at room
temperature for 2 min. Centrifuge the samples at 13,200  g for
10 min at 4 8C. Transfer the aqueous phase to a clean tube.
Precipitate the RNA from the aqueous phase by adding100 ml of
isopropyl alcohol per 250 ml of the TRIzol LS Reagent used for the
initial homogenization followed by vigorous vortexing (15 s) and
incubate at room temperature for 10 min. Centrifuge at 13,200  g
for 10 min at 4 8C. Remove the supernatant. Wash the RNA pellet
by adding100 ml of 75% ethanol per 250 ml of the TRIzol LS Reagent
used for the initial homogenization. Mix the samples by vortexing
(15 s) followed incubation at room temperature (2 min). Then
samples were centrifugated at 90  g for 10 min at 4 8C. Decant the
supernant, remove it as much as possible without disturbing the
pellet. Dry the RNA pellet at room temperature. Finally,
resolubilize the pelletin50 ml of H2O with diethyl pyrocabonate
(DEPC). The expected values of the A260/280 ratio of the total RNA
isolated were obtained by spectrometer. RNA extraction was
evaluated by 1% agarose gel electrophoresis. Bands (RNA18s and
28 s) of approximately 2 and 5 kilobase (kb) length were visualized
under light UV (transilluminator BioRads).
2.16. Statistical analysis
All experiments were carried out at least in duplicate. Each
group consisted of eight rats. One way analysis of variance
(ANOVA) was performed and Tukey post hoc test was used for
multiple comparisons. Statistical analyses were performed using
the InStat 3.0 program. The results are expressed as mean  SEM.
The results originated from analysis of serum and tissues. Linear
correlation tests were also performed. Differences of p < 0.05 were
considered signiﬁcant.
3. Results
3.1. Body weight
During the 4-week (experimental period), there was a weight
loss in untreated diabetic rats compared with normal healthy rats
(control) (p < 0.001) (Table 1). However, at the end of the
experimental treatment period there was an elevation in bodyulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
Table 1
Body weight in control (C), untreated diabetic rats (D), saffron extract (10 mg/kg/
day)-treated diabetic (D + Saf1), saffron extract (20 mg/kg/day)-treated diabetic
(D + Saf2) and saffron extract (40 mg/kg/day)-treated diabetic (D + Saf3) rats during
4 weeks of study.
Days 0 7 14 21 28
C 200  17 242  13 267  19 275  17 291  21
D 211  10 201  19* 195  14* 187  11** 178  12***
D + Saf1 218  12 210  8* 223  9* 230  11* 233  17**
D + Saf2 215  7 218  11 222  13 229  6*+ 237  10*+
D + Saf3 219  10 225  11 242  12+ 255  18++ 263  15++
Each measurement has been done at least in triplicate and the values are the
mean  SEM for nine rats in each group.
Signiﬁcantly different from normal rats (*p < 0.05, **p < 0.01, ***p < 0.001).
Signiﬁcantly different from STZ-treated rats (+p < 0.05, ++p < 0.01).
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compared to untreated diabetic rats (p < 0.05 and p < 0.01,
respectively), but the elevated body weight in the saffron extract
(10 and 20 mg/kg)-treated diabetic groups was signiﬁcantly lower
than the control group (p < 0.05 and p < 0.01, respectively)
(Table 1). At the highest saffron extract dose (40 mg/kg) there
were no signiﬁcant differences in body weight compared to control
rats after the 4-week experimental period (Table 1).
STZ-diabetic rats exhibited signiﬁcant (p < 0.001) hyperglyce-
mia compared to the control rats (Fig. 1). After 4 weeks the saffron
extract dose dependently decreased blood glucose levels in the
diabetic rats compared to the untreated diabetic rats (Fig. 1).
Saffron extract (10 mg/kg/day) signiﬁcantly decreased glucose in
STZ diabetic rats only at the 4th week of the study (p < 0.05), while
at 20 mg/kg/day saffron extract reduced blood glucose signiﬁcant-
ly at the 2nd, 3rd and 4th week from induction of diabetes
compared with untreated diabetic rats (p < 0.05 and p < 0. 01,
respectively). At the highest dose of saffron extract (40 mg/kg/day)
blood glucose of diabetic rats was signiﬁcantly reduced beginning
from the 2nd week of treatment (p < 0.05, p < 0.001) (Fig. 1).
3.2. Modulation of lipid proﬁle by saffron extract
STZ-injected rats showed signiﬁcant increases in the serum
levels of total lipids, triglycerides, total cholesterol andFig. 1. Effect of saffron on blood glucose level (mg/dl). Control (C), untreated diabetic ra
day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-treated diabetic (D + S3) rats d
signiﬁcance for the difference between the data of the control group vs other groups: *p < 0.0
untreated diabetic group vs treated groups: +p < 0.05; ++p < 0.01, +++p < 0.001.
Please cite this article in press as: Samarghandian S, et al. Immunomod
sativus L.) on streptozotocin-induced diabetes in rats, Indian Heart JLDL-cholesterol (LDL-C), and signiﬁcantly decreased serum
HDL-cholesterol (HDL-C) level compared to the control group
(p < 0.001) (Fig. 2). Saffron extract dose-dependently reduced
the serum levels of total lipids, triglycerides, total cholesterol
and LDL-C, and increased serum HDL-C level during the
experimental period (p < 0.05). At the highest saffron extract
dose (40 mg/kg/day) there was no signiﬁcant difference in total
lipid, cholesterol, LDL-C and HDL-C levels between the STZ-
treated rats and the control rats (Fig. 2).
3.3. Modulation of MDA value by saffron extract
STZ injection produced signiﬁcant changes in oxidative stress
parameters in the serum of diabetic rats 4 weeks after diabetes
induction, as shown by increased lipid peroxidation product
(MDA) compared to control group (p < 0.001) (Fig. 3). Saffron
extract (20 and 40 mg/kg/day) signiﬁcantly decreased the serum
MDA compared with the untreated diabetic groups (p < 0.05 and
p < 0.01, respectively) (Fig. 3). In addition, the MDA levels in
animals which were administrated with high saffron extract
concentration (40 mg/kg/day) were signiﬁcantly lower than the
diabetic rats receiving low saffron extract concentration (10 mg/
kg/day) (0.14  0.04 vs 0.52  0.09, p < 0.01) and MDA levels in
diabetic rats treated with the medium concentration (20 mg/kg/day)
were signiﬁcantly lower than the low saffron extract treated diabetic
rats (0.14  0.04 vs 0.33  0.05, p < 0.05). Furthermore, there was no
signiﬁcant difference between control rats and the high dose saffron
extract treated diabetic rats (Fig. 3).
3.4. Effect of saffron extract on GSH, SOD, CAT
GSH, SOD and CAT activities were decreased in the STZ-diabetic
group compared with the control group (p < 0.01) (Fig. 4). Saffron
extract (10, 20 and 40 mg/kg/day) treated diabetic rats had
signiﬁcantly increased serum GSH and SOD compared with the
untreated diabetic rats (p < 0.05). In addition, there was not a
signiﬁcant difference in CAT activity between diabetic rats treated
with high saffron extract concentration (40 mg/kg/day) and the
control group. The GSH, SOD and CAT activities in saffron extract
(10 and 20 mg/kg/day)-treated diabetic rats were slightly higherts (D), saffron extract (10 mg/kg/day)-treated diabetic (D + Sf1), saffron (20 mg/kg/
uring 4 weeks of study (n = 9, for each group). Values are the mean  SEM. Statistical
5; **p < 0.01, ***p < 0.001. Statistical signiﬁcance for the difference between the data of
ulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
Fig. 2. Effect of saffron extract on plasma lipid proﬁles (mg/dl). (a) total lipid, (b) total cholesterol (TC), (c) triglycerides, (d) LDL-C, (e) HDL-C, in control (C), untreated diabetic
rats (D), saffron (10 mg/kg/day)-treated diabetic (D + Sf1), saffron (20 mg/kg/day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-treated diabetic (D + Sf3) rats during
4 weeks of study (n = 9, for each group). Values are the mean  SEM. Statistical signiﬁcance for the difference between the data of the control group vs other groups: *p < 0.05;
**p < 0.01, ***p < 0.001. Statistical signiﬁcance for the difference between the data of untreated diabetes group vs treated groups: +p < 0.05; ++p < 0.01.
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signiﬁcant (Fig. 4). The effects on GSH, SOD and CAT were dose
dependent, the activities of serum GSH and SOD in animals
administrated with the high saffron extract dose (40 mg/kg) being
signiﬁcantly greater than that in the rats receiving low saffron
extract concentration (10 mg/kg) (0.5  0.26 vs 0.36  0.03,
p < 0.05) (6.1  0.29 vs 4.97  0.09, p < 0.05), respectively.Fig. 3. Effect of saffron extract on MDA. Serum MDA level (U/gp) in control (C),
untreated diabetic rats (D), saffron (10 mg/kg/day)-treated diabetic (D + Sf1),
saffron (20 mg/kg/day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-
treated diabetic (D + Sf3) rats during 4 weeks of study (n = 9, for each group). Values
are the mean  SEM. Statistical signiﬁcance for the difference between the data of the
control group vs other groups: *p < 0.05; **p < 0.01, ***p < 0.001. Statistical
signiﬁcance for the difference between the data of untreated diabetes group vs
treated groups: ++p < 0.01.
Please cite this article in press as: Samarghandian S, et al. Immunomod
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STZ injection produced a signiﬁcant increase of NO compared to
the control group (p < 0.001) (Fig. 5). Saffron extract (20 and
40 mg/kg/day)-treated diabetic rats had signiﬁcantly decreased
serum NO compared with the untreated diabetic rats (p < 0.05,
p < 0.01, respectively). The effects on NO were dose dependent,
serum NO levels of animals having been administrated high saffron
extract dose being signiﬁcantly lower than those in the diabetic
rats receiving the low saffron extract dose (8.3  0.6 vs 12.7  1.0,
p < 0.05); and NO levels in diabetic rats treated with a medium
concentration (20 mg/kg) were slightly lower than the low dose of
saffron extract-treated diabetic rats (10.5  0.8 vs 12.7  1.0,
p < 0.001).
3.6. Inhibition of inﬂammatory cytokines expression by saffron
extract
To further determine whether saffron extract regulates
inﬂammatory cytokines in diabetic rats, we determined the
expression of inﬂammatory cytokines from abdominal aorta
(Fig. 6) in the absence or presence of the different concentrations
of saffron extract and then we determined the expression levels of
TNF-a and IL-6 by using the RT-PCR analysis. The control rats did
not show expression of inﬂammatory cytokines due to the absence
of this condition; by contrast the diabetic rats expressed the both
inﬂammatory cytokines (TNF-a and IL-6). With respect to groupsulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
Fig. 4. Effect of saffron extract on serum GSH (a), SOD (b) and CAT (c) (U/gp). Control (C), untreated diabetic rats (D), saffron (10 mg/kg/day)-treated diabetic (D + Sf1), saffron
(20 mg/kg/day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-treated diabetic (D + S3) rats during 4 weeks of study (n = 9, for each group). Values are the
mean  SEM. Statistical signiﬁcance for the difference between the data of control vs other groups: *p < 0.05, **p < 0.01. Statistical signiﬁcance for the difference between the data
of diabetes vs treated groups: +p < 0.05.
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extract (10 mg/kg/day) only slightly inhibited expression of the
inﬂammatory cytokine sand, treatment of the diabetic rats with
the highest concentration of saffron extract (40 mg/kg/day)
signiﬁcantly down-regulated the levels of the pro-inﬂammatory
cytokine, so that, it was found be comparable with the control
animal sand. As the results shown in Fig. 6, saffron treatment
profoundly reduced TNF-a and IL-6 mRNA expression in the
diabetic rats in a dose dependent manner. GAPDH was used as a
loading control. All treatments expressed the constitutive GAPDH
gen (Table 2).
4. Discussion
The incidence of DM is sharply increasing worldwide which
represents a critical burden or patients and for the society as wellFig. 5. Effect of saffron extract on serum NO (mM/l). Control (C), untreated diabetic
(D), diabetic and (10 mg/kg/day) saffron (20 mg/kg/day)-treated diabetic (D + Sf1),
saffron (20 mg/kg/day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-
treated diabetic (D + Sf3) rats during 4 weeks of study (n = 9, for each group). Values
are the mean  SEM. Statistical signiﬁcance for the difference between the data of
control vs other groups: *p < 0.05; **p < 0.01, ***p < 0.001. Statistical signiﬁcance for
the difference between the data of untreated diabetes vs treated groups: +p < 0.05;
++p < 0.01.
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sativus L.) on streptozotocin-induced diabetes in rats, Indian Heart Jdue to micro- and macro-vascular complications. The risk factors
for the development of vascular disease in subjects with DM are
obesity, the presence of poor glycemic control, dyslipidemia,
imbalance of oxidant/antioxidant, and inﬂammation. Our present
data indicate that intraperitoneal injection of saffron extract
signiﬁcantly ameliorated the adverse metabolic effects in rats
treated with STZ. Despite glucose-lowering effect of saffron
extract was not observed for control rats (data was not shown), we
found saffron extract mildly caused a decrease in fast blood
glucose in DM rats, which was in agreement with several
studies.40,41 This change in blood glucose caused by saffron
extract could contribute to the improvement in endothelial cell
dysfunction, which is induced by hyperglycemia through multiple
pathways including enhanced glycolysis, the buildup of glycolytic
intermediates, and AGE-modiﬁcation of proteins.42 In addition,
we observed saffron extract attenuated lipid abnormalities
including TC, TG, LDL-C in DM rats, that may due to increased
plasma lipid uptake by the liver and adipose tissue or by decreased
hepatic cholesterol genesis and fatty acid synthesis.41 Although,
saffron extract treatment did not signiﬁcantly inﬂuence body
weight within groups of non diabetic (data was not shown) but,
the saffron extract signiﬁcantly enhanced body weight in diabetic
rats at the end of experimental period. Therefore, the saffron
extract injection after STZ treatment resulted in decrease in serum
glucose level, and also improved lipid proﬁle as well as body
weight as compared with untreated diabetic rats. Furthermore,
the saffron extract treatment of diabetic rats were observed to
signiﬁcantly recover the decreased levels of GSH, CAT and SOD, as
well as the decline in the lipid proﬁles and the oxidative stress
parameters MDA and NO compared with untreated diabetic
group. These results are compatible with the ﬁndings reported by
other investigators using saffron and its active constituent, crocin,
which improved oxidative damage due to ischemia and injury in
rats.24,28,29 The results in the current study are consistent with
amelioration of oxidative stress in the STZ diabetic rats. The
effects observed in lipid proﬁle and hyperglycemia that induced
by diabetes in rats in the present study are similar to the ﬁndings
reported by other investigations using STZ to induce diabetes in
rats, accompanied by an increase in the susceptibility to lipid
peroxidation.43,44ulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
Fig. 6. Effect of saffron extract on proinﬂammatory genes (TNF-a and IL-6) in abdominal aorta. Control (C), untreated diabetic (D), diabetic and (10 mg/kg/day) saffron (20 mg/
kg/day)-treated diabetic (D + Sf1), saffron (20 mg/kg/day)-treated diabetic (D + Sf2) and saffron (40 mg/kg/day)-treated diabetic (D + Sf3) rats during 4 weeks of study (n = 9,
for each group).
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and the pathogenesis of diabetes.
Hyperglycemia results in overproduction of oxygen free
radicals, which contributes to the complications of diabetes and
its progression.43 Several studies have shown that STZ produces
imbalance between plasma oxidant and antioxidant content,
resulting in the development of DM and its complications.
In our experimental model of diabetes mellitus, it was seen that
STZ administration led to a signiﬁcant decrease in plasma GSH
content and CAT and SOD activities, accompanied by a signiﬁcant
increase in MDA, NO and overall lipid proﬁle, indicating an
increased plasma oxidative stress which may also occur in the
different tissues in STZ treated rats. Increasing evidence suggests
that oxidative stress and changes in nitric oxide formation or
action play major roles in the onset of diabetic complications such
as atherosclerosis. The improvement of variable measurements in
STZ-diabetic rats after saffron extract treatment might suggest a
protective inﬂuence of saffron against STZ action that could be
mediated through suppression of oxygen free radicals induced by
STZ. A stimulating effect of the formation of GSH by saffron extract
was observed in the present study. The GSH reacts with free
radicals and is a crucial substrate for glutathione peroxidase and
glutathione-S-transferase, which take part in the cellular defense
mechanisms against intermediate oxygen products.45,46 It may be
relevant that the ratio of GSH/GSSG plays a important role in
glucose homeostasis of diabetes because thiol groups are critical in
intracellular and membrane redox state.45 Saffron extract induced
an increase in plasma GSH content, which might enhance the GSH/
GSSG ratio and decrease lipid peroxidation, hence aldehydic
concentration, and therefore improve serum glucose regulation.
Parallel to these events, plasma CAT and SOD activity were
increased in saffron extract treated diabetic rats as compared with
untreated diabetic rats. SOD is responsible for removal of
superoxide radicals and catalase decomposes hydrogen peroxide
to water and oxygen; thus, these enzymes may contribute to the
modulation of redox state of plasma.48 This observation perfectly
agrees with those of Kianbakht et al. (2011) who observed that
saffron, crocin and safranal may effectively control glycemia in the
alloxan induced diabetes rat model.47,48 The results of the present
study indicate that saffron extract is also effective to prevent
hyperlipidemia due to diabetes. Saffron extract inhibits elevation
of the serum lipid proﬁle by controlling oxidative and nitrosative
systems. Saffron has been reported to help lower cholesterol and
keep cholesterol at healthy levels.49 In agreement with previous
studies, one mechanism for the hypolipidemic effect of saffron
extract has proposed inhibitory effects on the levels of MDA,
oxygen free radical and activating superoxide dismutase.50Table 2
Primers of the polymerase chain reaction (PCR) assay. IL-6, interleukin-6; TNF-a,
tumor necrosis factor-a; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Sense (50–30) Anti-sense (30–50) Size
(bp)
IL-6 GGGACTGATGTTGTTGACAG TGTTCTTCACAAACTCCAGG 304
TNF-a CCCAGACCCTCACACTCAGAT TTGTCCCTTGAAGAGAACCTG 215
GAPDH ACCACCATGGAGAAGGCTGG CTCAGTGTAGCCCAGGATGC 528
Please cite this article in press as: Samarghandian S, et al. Immunomod
sativus L.) on streptozotocin-induced diabetes in rats, Indian Heart JReactive oxygen species are increased by hyperglycemia. Hyper-
glycemia, which occurs during diabetes (both type 1 and type 2)
and, to a lesser extent, during insulin resistance, causes oxidative
stress. Elevated glucose in diabetes may also react with lipids,
resulting in the generation of ROS.51 Diabetes mellitus often
includes lipid abnormalities such as elevated LDL-C and choles-
terol, and such effects were shown in this in vivo study. These
abnormalities may be further exacerbated by the increased
oxidizing environment which enhances the formation of oxidized
LDLs (oxLDLs), glycated LDL and oxysterols (formed from the
oxidation of cholesterol). It has been suggested that these oxidized
lipid products can bind to speciﬁc receptor proteins or activate
inﬂammatory proteins which generate ROS.51
In our study, prooxidant- antioxidant balance was evaluated by
measuring MDA and NO levels and enzymatic antioxidants in the
diabetic rats. Increased MDA, NO and decreased SOD, GST and CAT
activities indicated that the balance changed toward prooxidation
in STZ-induced diabetic rats. Saffron extract treatment of diabetic
rats, which restored SOD, GST and CAT activities, may be due to a
decrease in free radical generation by saffron extract and increased
antioxidant defenses (12). Saffron extract showed good antioxi-
dant activity in vivo.52,53 Saffron administration regulates the
expression of antioxidant related genes, and consequently oxidant
levels in diabetic animals. In biological systems saffron shows its
antioxidant impact via stabilizing membranes,29 inhibiting ROS
and reducing peroxidation of unsaturated membrane fatty acids.25
Saffron has been known to function as a radical scavenger
inhibiting lipid peroxidation in vivo and in vitro. It also has been
reported that saffron supplementation could decrease lipid
peroxidation.32,54 Saffron modulates antioxidant gene expression
and also upregulates mitochondrial antioxidant genes, leading to a
lower mitochondrial oxygen radical generation, which may be
responsible at least in part for the improved hyperglycemia,
hyperlipidemia and oxidative stress seen in the present study in
STZ induced diabetic rats. Additionally, increased SOD, GST and
CAT levels after saffron extract treatment may play an additional
role in decreasing oxidative stress. The present study elucidated
the antihyperglycemia, hypolipidemic and protective potential of
saffron extract treatment on activities of antioxidant enzymes
(SOD, GST, CAT), lipid peroxidation levels and serum NO content in
the STZ diabetic rat model. In conﬁrm with our current data, it has
been shown that aqueous extract of saffron ameliorates isoproter-
enol-induced myocardial injury via strengthening antioxidant
defense system.55
It is well known that obese, hyperlipidemia, and imbalance of
oxidant/antioxidant exhibit a state of chronic low grade inﬂam-
mation, and such activation of inﬂammatory pathways have also
been proposed as a major driver of obese and insulin resis-
tance.56,57 The cytokines are involved in the chronic inﬂammatory
processes of the vessels wall, promoting lipid accumulation with
consequent development of vasculopathy. Our data suggested that
saffron extract inhibited production of the inﬂammatory media-
torsIL-6 and TNF-a in DM rats. Our results and ﬁndings of other
laboratories58 indicated that diabetes represented a multifactorial
vasculopathy involving various aspects of inﬂammatory and
metabolic syndrome based on a combination of hyperglycemia,ulatory and antioxidant effects of saffron aqueous extract (Crocus
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.008
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showed enhanced atherosclerotic plaque burden with more distal
plaques compared to DM.59 Thus, identifying that a novel
compound like saffron extract not only inhibit vascular inﬂamma-
tion, but also attenuate the hyperglycemia and hyperlipidemia
classically associated with atherosclerotic plaque formation holds
great promise for the prevention of vascular complications in
patients with DM.
Atherosclerosis, as well as vasculopathy in type2 diabetes, is a
chronic inﬂammatory disease, and pathological and epidemiologi-
cal evidence suggest that proinﬂammatory cytokines play a key
role or chest rating the pathological processes underlying the
development of the atherosclerotic plaque.60 TNF-a impairs
vascular endothelial cells and affects endothelial permeability
possibly through an activation of tyrosine kinases both in vitro and
in vivo. TNF-a may stimulate endothelial cells to upregulate
adhesion molecule such as ICAM-1 which coincide with the
earliest phases of local endothelial activation and contribute to
endothelial–monocyte interactions in early atherogenesis.61 In-
duction of CAM-1 by TNF-a enhances the adhesion of neutrophils
to endothelial cells, which initiate and aggravate the cascade of
other inﬂammatory mediators.62,63 Therefore, we detected the
expression levels of TNF-a and IL-6 in abdominal aorta among the
experimental groups. Our data demonstrated that the increases in
the expression levels of TNF-a and IL-6 in abdominal aorta of
untreated diabetic rats, but saffron extract decreased dose
dependently the expression of TNF-a and IL-6 in aorta of the
treated diabetic rats. We speculated that the vascular protective
effects of saffron might be correlated with diminution of
inﬂammation response. Thus our ﬁndings would be of great
signiﬁcance, showing that saffron extract can abrogate the
development of a vascular injury microenvironment in the
vascular wall of DM rats. But the mechanisms by which saffron
exert anti-inﬂammatory effects is not clear. However, it is logical to
hypothesize that saffron appears to regulate high glucose-induced
proinﬂammatory mediator production. This view is in line with
other study showing that saffron blocked TNF-a and IL-6 in
endothelial of abdominal aorta to inhibit upregulation of
inﬂammatory mediators.64 Saffron and its main ingredient
(safranal) are antioxidants; it seems that inhibitory effects of
saffron are also mainly attributed to its antioxidant action. Finally,
our studies showed saffron suppressed and further down-
regulated the mRNA expression of TNF-a and Il-6 indicating that
that saffron inhibited the activation of inﬂammatory signaling
induced by high glucose that would mimic the effect of
vasculopathy in diabetes.
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